Metabolically more active tumors, tissues derived from metastases, as well as tumors with CD133+ cancer-initiating cells also showed higher frequencies of xenograft establishment, suggesting that the tumor take rate reflects the aggressiveness of the transplanted tumor [34]. Here, PROM1 is linked to cancer.